- Home
- NFGC vs SIBN Comparison
NFGC vs SIBN Comparison
Compare NFGC & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NFGC | SIBN |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 588.1M | 606.1M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NFGC | SIBN |
|---|---|---|
| Price | $3.03 | $19.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $5.00 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 1.5M | 712.3K |
| Earning Date | 11-07-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,578,000.00 |
| Revenue This Year | N/A | $21.44 |
| Revenue Next Year | N/A | $15.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23.27 |
| 52 Week Low | $0.93 | $12.50 |
| 52 Week High | $3.03 | $20.05 |
Technical Indicators
Market Signals| Indicator | NFGC | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 77.03 | 65.38 |
| Support Level | $2.03 | $18.83 |
| Resistance Level | $2.90 | $19.80 |
| Average True Range (ATR) | 0.16 | 0.72 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 99.40 | 77.49 |
Price Performance
Historical ComparisonAbout NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.